(Q40835345)

24 September 2017

title

In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients (English)

1 reference

24 September 2017

0 references

E Izbicka

1

1 reference

24 September 2017

R Lawrence

2

1 reference

24 September 2017

E Raymond

3

1 reference

24 September 2017

G Eckhardt

4

1 reference

24 September 2017

G Faircloth

5

1 reference

24 September 2017

J Jimeno

6

1 reference

24 September 2017

G Clark

7

1 reference

24 September 2017

D D Von Hoff

8

1 reference

24 September 2017

publication date

1 September 1998

1 reference

24 September 2017

1 reference

24 September 2017

volume

9

1 reference

24 September 2017

issue

9

1 reference

24 September 2017

page(s)

981-987

1 reference

Additional antitumor ecteinascidins from a Caribbean tunicate: crystal structures and activities in vivo

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Characterisation of antimitotic products from marine organisms that disorganise the microtubule network: ecteinascidin 743, isohomohalichondrin-B and LL-15.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Primary Bioassay of Human Myeloma Stem Cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Primary Bioassay of Human Tumor Stem Cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Effect of recombinant interferon-beta ser on primary human tumor colony-forming units

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Activity of a recombinant transforming growth factor-alpha-Pseudomonas exotoxin hybrid protein against primary human tumor colony-forming units

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human tumor colony forming units

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Lack of effects of recombinant human interleukin-4 on in vitro colony formation of freshly explanted human tumor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Activity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming units

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Effects of the hematopoietic growth factors GM-CSF, IL-3, and IL-6 on human tumor colony-forming units taken directly from patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Activity of the morpholino anthracycline 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin (MX2) against human tumor colony-forming units in vitro.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Activity of TER286 against human tumor colony-forming units

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Structure and function of telomeres

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Telomere loss: mitotic clock or genetic time bomb?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Do telomerase antagonists represent a novel anti-cancer strategy?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008224322396

7 January 2021

Identifiers

DOI

10.1023/A:1008224322396

1 reference

24 September 2017

1 reference